SMART Technologies and the University of Melbourne s collaborative research promise impactful ways to engage neurodivergent students.
SMART Technologies, a global leader in interactive education technology, has partnered with the University of Melbourne to launch the first-of-its-kind research initiative exploring how classroom environments can better support neurodivergent learners. The study identified key strategies and tools that promote engagement, reduce barriers, and empower these studen
– Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine
– Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields
The nomination period for the Broermann Medical Innovation Award has started. The prize, which will be awarded for the first time this year, is aimed at scientists worldwide who have carried out pioneering work in medicine, biotechnology, or related fields with their research.
– Large deal TCV of $2.5 billion including 63% net new; Headcount increased by 5,591
– FY25 revenue guidance revised to 4.5%-5.0%
Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, delivered strong and broad-based performance with $4,939 million in Q3 revenues, growth of 1.7% sequentially and 6.1% year on year in constant currency. Operating margin for Q3 was at 21.3%, increase of 0.2% sequentially. Free cash flow for Q3 was high
Launch of Beyond Tennis : A new generative AI tennis league with AI players and data-driven tournaments
Infosys (https://www.infosys.com/) (NSE: INFY), (BSE: INFY), (NYSE: INFY), a global leader in next-generation digital services and consulting, in partnership with Tennis Australia (https://apc01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.tennis.com.au%2F&data=05%7C02%7CShruti.Pai%40infosys.com%7Ce74a953ce42e4341f62a08dd33a3fc68%7C63ce7d592f3e42cda8ccbe764cff5eb6%7C0%7C0%7C63
Premiering new products in the field of plating technologies and processes to help meet rising needs in the electronics industry, including for automotive electronic components and semiconductors
The Autonomous Sperm Selection AI-based Robotic System is Poised to Transform the IVF Market
BAIBYS™ (https://www.baibys.com/), a pioneering Israeli startup in AI-powered micro-robotics for Artificial Reproductive Technology (ART), today announced it has received the CE mark for its innovative BAIBYS™ system (https://www.youtube.com/watch?v=Vaa_HlxuAm0). This milestone enables the company to commercialize its autonomous sperm selection technology across Europe, marking a significant
SEATTLE, WA, Jan 6, 2025 – (ACN Newswire) – Spectral Capital Corporation (OTCQB: FCCN), a pioneer in Quantum as a Service (QaaS) computing and decentralized cloud infrastructure, is pleased to announce the achievement of a major patent milestone as the first step in its plan to become a globally competitive leader in quantum computing patents.
"According to the World Intellectual Property Organization ("WIPO"), there were 350,000 patents filed worldwide in classical computing. An
Back to media releases (https://norgine.com/media)
Next media release (https://norgine.com/press_release/norgine-receives-positive-chmp-opinion-recommending-approval-of-npj5008-dantrolene-sodium-hemiheptahydrate-for-the-treatment-of-malignant-hyperthermia/)
Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, i
As part of the EU-funded APRIORA project, drug residues are being analysed. Scientists from the University of Rostock are taking water samples in all weathers. The aim is to use innovative approaches to improve wastewater treatment in Europe.
The Warnow seems to be flowing uphill on this cold morning, but it is only the wind that pushes the surface in strong gusts against the direction of flow. This part of the Warnow lies in a nature reserve. The reeds along its banks are home to valuable fa
![Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma](https://www.so-co-it.com/wp-content/uploads/716035.jpg "Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma")
